147 related articles for article (PubMed ID: 27346061)
1. Mortality among workers exposed to toluene diisocyanate in the US polyurethane foam industry: Update and exposure-response analyses.
Pinkerton LE; Yiin JH; Daniels RD; Fent KW
Am J Ind Med; 2016 Aug; 59(8):630-43. PubMed ID: 27346061
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence and mortality of isocyanate exposed workers from the Swedish polyurethane foam industry: updated findings 1959-98.
Mikoczy Z; Welinder H; Tinnerberg H; Hagmar L
Occup Environ Med; 2004 May; 61(5):432-7. PubMed ID: 15090664
[TBL] [Abstract][Full Text] [Related]
3. A 17-year epidemiological study on changes in lung function in toluene diisocyanate foam workers.
Clark RL; Bugler J; Paddle GM; Chamberlain JD; Allport DC
Int Arch Occup Environ Health; 2003 May; 76(4):295-301. PubMed ID: 12684809
[TBL] [Abstract][Full Text] [Related]
4. Inception cohort study of workers exposed to toluene diisocyanate at a polyurethane foam factory: initial one-year follow-up.
Gui W; Wisnewski AV; Neamtiu I; Gurzau E; Sparer JA; Stowe MH; Liu J; Slade MD; Rusu OA; Redlich CA
Am J Ind Med; 2014 Nov; 57(11):1207-15. PubMed ID: 25266741
[TBL] [Abstract][Full Text] [Related]
5. Mortality and cancer morbidity of production workers in the UK flexible polyurethane foam industry: updated findings, 1958-98.
Sorahan T; Nichols L
Occup Environ Med; 2002 Nov; 59(11):751-8. PubMed ID: 12409534
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry.
Hagmar L; Welinder H; Mikoczy Z
Br J Ind Med; 1993 Jun; 50(6):537-43. PubMed ID: 8392362
[TBL] [Abstract][Full Text] [Related]
7. Dermal exposure to toluene diisocyanate and respiratory cancer risk.
Prueitt RL; Lynch HN; Zu K; Shi L; Goodman JE
Environ Int; 2017 Dec; 109():181-192. PubMed ID: 28967432
[TBL] [Abstract][Full Text] [Related]
8. An epidemiology study of lung function changes of toluene diisocyanate foam workers in the United Kingdom.
Clark RL; Bugler J; McDermott M; Hill ID; Allport DC; Chamberlain JD
Int Arch Occup Environ Health; 1998 May; 71(3):169-79. PubMed ID: 9591158
[TBL] [Abstract][Full Text] [Related]
9. Toluene diisocyanate exposures in the flexible polyurethane foam industry.
Rando RJ; Abdel-Kader H; Hughes J; Hammad YY
Am Ind Hyg Assoc J; 1987 Jun; 48(6):580-5. PubMed ID: 3039821
[TBL] [Abstract][Full Text] [Related]
10. Diurnal variation in peak expiratory flow rate among workers exposed to toluene diisocyanate in the polyurethane foam manufacturing industry.
Lee HS; Phoon WH
Br J Ind Med; 1992 Jun; 49(6):423-7. PubMed ID: 1318731
[TBL] [Abstract][Full Text] [Related]
11. Biological monitoring as a valid tool to assess occupational exposure to mixtures of 2,4-:2,6-toluene diisocyanate.
De Palma G; Cortesi I; Ghitti R; Festa D; Bergonzi R; Apostoli P
Med Lav; 2012; 103(5):361-71. PubMed ID: 23077796
[TBL] [Abstract][Full Text] [Related]
12. Respiratory effects in toluene diisocyanate manufacture: a multidisciplinary approach.
Weill H; Salvaggio J; Neilson A; Butcher B; Ziskind M
Environ Health Perspect; 1975 Jun; 11():101-8. PubMed ID: 170075
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of self-reported skin problems among workers exposed to toluene diisocyanate (TDI) at a foam manufacturing facility.
Daftarian HS; Lushniak BD; Reh CM; Lewis DM
J Occup Environ Med; 2002 Dec; 44(12):1197-202. PubMed ID: 12500464
[TBL] [Abstract][Full Text] [Related]
14. Toluene diisocyanate emission to air and migration to a surface from a flexible polyurethane foam.
Vangronsveld E; Berckmans S; Spence M
Ann Occup Hyg; 2013 Jun; 57(5):650-61. PubMed ID: 23680588
[TBL] [Abstract][Full Text] [Related]
15. Air exposure assessment of TDI and biological monitoring of TDA in urine in workers in polyurethane foam industry.
Geens T; Dugardin S; Schockaert A; De Cooman G; van Sprundel M
Occup Environ Med; 2012 Feb; 69(2):93-8. PubMed ID: 21725071
[TBL] [Abstract][Full Text] [Related]
16. Industrial hygiene sampling for airborne TDI in six flexible slabstock foam manufacturing facilities in the United States: a comparison of the short-term and long-term sampling data.
Cummings BJ; Booth KS
Appl Occup Environ Hyg; 2002 Dec; 17(12):863-71. PubMed ID: 12495597
[TBL] [Abstract][Full Text] [Related]
17. Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry.
Schnorr TM; Steenland K; Egeland GM; Boeniger M; Egilman D
Occup Environ Med; 1996 Oct; 53(10):703-7. PubMed ID: 8943836
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry.
Collins JJ; Anteau S; Conner PR; Cassidy LD; Doney B; Wang ML; Kurth L; Carson M; Molenaar D; Redlich CA; Storey E
J Occup Environ Med; 2017 Dec; 59 Suppl 12(Suppl 12):S22-S27. PubMed ID: 29200135
[TBL] [Abstract][Full Text] [Related]
19. Biological monitoring of occupational exposure to toluene diisocyanate: measurement of toluenediamine in hydrolysed urine and plasma by gas chromatography-mass spectrometry.
Persson P; Dalene M; Skarping G; Adamsson M; Hagmar L
Br J Ind Med; 1993 Dec; 50(12):1111-8. PubMed ID: 8280642
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment for consumer exposure to toluene diisocyanate (TDI) derived from polyurethane flexible foam.
Arnold SM; Collins MA; Graham C; Jolly AT; Parod RJ; Poole A; Schupp T; Shiotsuka RN; Woolhiser MR
Regul Toxicol Pharmacol; 2012 Dec; 64(3):504-15. PubMed ID: 22871374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
